- Home
- FEMY vs GXAI Comparison
FEMY vs GXAI Comparison
Compare FEMY & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEMY
- GXAI
- Stock Information
- Founded
- FEMY 2004
- GXAI 2021
- Country
- FEMY United States
- GXAI United States
- Employees
- FEMY N/A
- GXAI N/A
- Industry
- FEMY Medical/Dental Instruments
- GXAI
- Sector
- FEMY Health Care
- GXAI
- Exchange
- FEMY Nasdaq
- GXAI Nasdaq
- Market Cap
- FEMY 12.5M
- GXAI 12.0M
- IPO Year
- FEMY 2021
- GXAI 2023
- Fundamental
- Price
- FEMY $0.60
- GXAI $1.82
- Analyst Decision
- FEMY Strong Buy
- GXAI
- Analyst Count
- FEMY 3
- GXAI 0
- Target Price
- FEMY $7.33
- GXAI N/A
- AVG Volume (30 Days)
- FEMY 6.9M
- GXAI 338.8K
- Earning Date
- FEMY 11-11-2025
- GXAI 11-13-2025
- Dividend Yield
- FEMY N/A
- GXAI N/A
- EPS Growth
- FEMY N/A
- GXAI N/A
- EPS
- FEMY N/A
- GXAI N/A
- Revenue
- FEMY $1,887,016.00
- GXAI $198,711.00
- Revenue This Year
- FEMY $103.55
- GXAI N/A
- Revenue Next Year
- FEMY $148.13
- GXAI N/A
- P/E Ratio
- FEMY N/A
- GXAI N/A
- Revenue Growth
- FEMY 98.61
- GXAI 72158.55
- 52 Week Low
- FEMY $0.31
- GXAI $1.00
- 52 Week High
- FEMY $1.80
- GXAI $7.50
- Technical
- Relative Strength Index (RSI)
- FEMY 59.98
- GXAI 56.27
- Support Level
- FEMY $0.34
- GXAI $1.55
- Resistance Level
- FEMY $0.92
- GXAI $1.94
- Average True Range (ATR)
- FEMY 0.06
- GXAI 0.14
- MACD
- FEMY 0.05
- GXAI 0.01
- Stochastic Oscillator
- FEMY 50.50
- GXAI 66.64
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.